JPRN-UMIN000026520尚未招募2 期
The efficacy and safety of enzalutamide in patients with non-muscle invasive bladder cancer - The efficacy and safety of enzalutamide in patients with non-muscle invasive bladder cancer
rology department of Tsukuba University Hospital0 个研究点目标入组 10 人开始时间: 2017年3月15日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- Male
入选标准
- 未提供
排除标准
- •history of androgen deprivation therapy
研究者
相似试验
已完成
不适用
Investigation of clinical efficacy of Enzalutamide and its predictive factors in CRPC patientscastration resistant prostate cancerJPRN-UMIN000015996Keio University School of Medicine50
已完成
2 期
Safety and Efficacy Study of Enzalutamide in Patients With Advanced, Androgen Receptor-Positive, Triple Negative Breast CancerAdvanced, Androgen Receptor Positive Triple Negative Breast CancerNCT01889238Pfizer118
已完成
不适用
The efficacy and safety of enzalutamide for castrate-resistant prostate cancer patient showing disease progression after or during chemotherapy including docetaxel.Castrate-resistant prostate cancerJPRN-UMIN000023627Kumamoto University20
已完成
2 期
A Study of Enzalutamide Versus Bicalutamide in Castrate Men With Metastatic Prostate CancerProstatic NeoplasmsNCT01288911Astellas Pharma Inc375
进行中（未招募）
1 期
Enzalutamide Treatment of Metastatic Castration-Resistant Prostate Cancer Patients after Abiraterone AcetateEUCTR2013-002271-17-DEAstellas Pharma Europe B.V.200